Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.
Company Details
- Employees
- 32
- Founded
- -
- Address
- Research Triangle Park, North Carolina, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.areteiatx.com
- HQ
- Research Triangle Park, North Carolina
Areteia Therapeutics Questions
Areteia Therapeutics's website is http://www.areteiatx.com
Areteia Therapeutics's LinkedIn profile is https://www.linkedin.com/company/areteiatherapeutics
Areteia Therapeutics has
32 employees.
View email and phone details for 32
employees at Areteia Therapeutics.
Areteia Therapeutics's industry is
Biotechnology Research
Areteia Therapeutics's top competitors are
Parexel,
Population Health Partners,
Validae Health,
Nextpoint Therapeutics, Inc.,
Latigo Biotherapeutics, Inc.,
Metsera,
Curve Therapeutics,
Kenai Therapeutics,
Pathalys Pharma,
The Medicines Company.
Areteia Therapeutics's categories are Biotechnology Research
Areteia Therapeutics's founding year is 2022
